Cancer Research Cancer Epigenetics  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jiang, X.-H.
Right arrow Articles by Wong, B. C.-Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jiang, X.-H.
Right arrow Articles by Wong, B. C.-Y.
[Cancer Research 64, 5787-5794, August 15, 2004]
© 2004 American Association for Cancer Research


Regular Articles

Antisense Targeting Protein Kinase C {alpha} and ß1 Inhibits Gastric Carcinogenesis

Xiao-Hua Jiang1,2, Shui-Ping Tu1,2, Jian-Tao Cui2, Marie C. M. Lin3, Harry H. X. Xia2, Wai Man Wong2, Annie On-On Chan2, Man Fung Yuen2, Shi-Hu Jiang1, Shiu-Kum Lam2, Hsiang-Fu Kung3, Jae Won Soh4, I. Bernard Weinstein4 and Benjamin Chun-Yu Wong2

Department of 1 Gastroenterology, Rui-jin Hospital, Shanghai, P.R. China; 2 Department of Medicine and 3 Institute of Molecular Biology, University of Hong Kong, Hong Kong; and 4 Department of Medicine and Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, Columbia University, New York, New York

Protein kinase C (PKC) family, which functions through serine/threonine kinase activity, is involved in signal transduction pathways necessary for cell proliferation, differentiation, and apoptosis. Its critical role in neoplastic transformation and tumor invasion renders PKC a potential target for anticancer therapy. In this study, we investigated the effect of targeting individual PKCs on gastric carcinogenesis. We established gastric cancer cell lines stably expressing antisense PKC{alpha}, PKCß1, and PKCß2 cDNA. These stable transfectants were characterized by cell morphology, cell growth, apoptosis, and tumorigenicity in vitro and in vivo. PKC{alpha}-AS and PKCß1-AS transfectants showed a different morphology with flattened, long processes and decreased nuclear:cytoplasmic ratio compared with the control cells. Cell growth was markedly inhibited in PKC{alpha}-AS and PKCß1-AS transfectants. PKC{alpha}-AS and PKCß1-AS cells were more responsive to mitomycin C- or 5-fluorouracil-induced apoptosis. However, antisense targeting of PKCß2 did not have any significant effect on cell morphology, cell growth, or apoptosis. Furthermore, antisense inhibition of PKC{alpha} and PKCß1 markedly suppressed colony-forming efficiency in soft agar and in nude mice xenografts. Inhibition of PKC{alpha} or PKCß1 significantly suppressed transcriptional and DNA binding activity of activator protein in gastric cancer cells, suggesting that PKC{alpha} or PKCß1 exerts their effects on cell growth through regulation of activator protein activity. These data provide evidence that targeting PKC{alpha} and PKCß1 by antisense method is a promising therapy for gastric cancer.




This article has been cited by other articles:


Home page
Cancer Res.Home page
K.-W. Lee, S. G. Kim, H.-P. Kim, E. Kwon, J. You, H.-J. Choi, J.-H. Park, B.-C. Kang, S.-A. Im, T.-Y. Kim, et al.
Enzastaurin, a Protein Kinase C{beta} Inhibitor, Suppresses Signaling through the Ribosomal S6 Kinase and Bad Pathways and Induces Apoptosis in Human Gastric Cancer Cells
Cancer Res., March 15, 2008; 68(6): 1916 - 1926.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X.-q. Wang, Q. Yan, P. Sun, J.-W. Liu, L. Go, S. M. McDaniel, and A. S. Paller
Suppression of Epidermal Growth Factor Receptor Signaling by Protein Kinase C-{alpha} Activation Requires CD82, Caveolin-1, and Ganglioside
Cancer Res., October 15, 2007; 67(20): 9986 - 9995.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y.-H. Hsieh, T.-T. Wu, C.-Y. Huang, Y.-S. Hsieh, J.-M. Hwang, and J.-Y. Liu
p38 Mitogen-Activated Protein Kinase Pathway Is Involved in Protein Kinase C{alpha}-Regulated Invasion in Human Hepatocellular Carcinoma Cells
Cancer Res., May 1, 2007; 67(9): 4320 - 4327.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Li and I. B. Weinstein
Protein Kinase C {beta} Enhances Growth and Expression of Cyclin D1 in Human Breast Cancer Cells
Cancer Res., December 1, 2006; 66(23): 11399 - 11408.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
V. Aaltonen, J. Koivunen, M. Laato, and J. Peltonen
Heterogeneity of Cellular Proliferation within Transitional Cell Carcinoma: Correlation of Protein Kinase C Alpha/betaI Expression and Activity
J. Histochem. Cytochem., July 1, 2006; 54(7): 795 - 806.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Hara, Y. Saito, T. Hirai, K. Nakamura, K. Nakao, M. Katsuki, and K. Chida
Deficiency of Protein Kinase C{alpha} in Mice Results in Impairment of Epidermal Hyperplasia and Enhancement of Tumor Formation in Two-Stage Skin Carcinogenesis
Cancer Res., August 15, 2005; 65(16): 7356 - 7362.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.